Cargando…

Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study

BACKGROUND: The aim of this study was to investigate the clinicopathological characteristics, treatment, and survival of cystadenocarcinoma of the salivary gland. PATIENTS AND METHODS: Cases in the Surveillance, Epidemiology, and End Results database from 1991 to 2012 were identified. Factors signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Cheng-Fu, Sun, Jia-Yuan, He, Zhen-Yu, Lin, Huan-Xin, Liu, Fa-Rong, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087798/
https://www.ncbi.nlm.nih.gov/pubmed/27822061
http://dx.doi.org/10.2147/OTT.S111247
_version_ 1782463974240944128
author Cai, Cheng-Fu
Sun, Jia-Yuan
He, Zhen-Yu
Lin, Huan-Xin
Liu, Fa-Rong
Wang, Yan
author_facet Cai, Cheng-Fu
Sun, Jia-Yuan
He, Zhen-Yu
Lin, Huan-Xin
Liu, Fa-Rong
Wang, Yan
author_sort Cai, Cheng-Fu
collection PubMed
description BACKGROUND: The aim of this study was to investigate the clinicopathological characteristics, treatment, and survival of cystadenocarcinoma of the salivary gland. PATIENTS AND METHODS: Cases in the Surveillance, Epidemiology, and End Results database from 1991 to 2012 were identified. Factors significantly associated with survival were identified using Kaplan–Meier survival analysis and Cox proportional hazard regression. RESULTS: A total of 65 patients were identified; of these patients, 64 received surgical treatment, 25 underwent lymphadenectomy, and four (16.0%) patients had nodal metastasis and only one (2.1%) patient had poorly differentiated disease. The most common tumor location was the parotid gland (87.7%). The median follow-up was 55 months. None of the patients died of salivary gland malignant-tumor-related disease. The 5- and 10-year cause-specific survival rates were 97.0% and 81.4%, respectively. The 5- and 10-year overall survival rates were 84.6% and 60.7%, respectively. Surgical procedures, lymphadenectomy, and adjuvant radiotherapy did not affect survival. CONCLUSION: Salivary gland cystadenocarcinoma is extremely rare but has an excellent prognosis, and surgery is the mainstay of treatment.
format Online
Article
Text
id pubmed-5087798
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50877982016-11-07 Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study Cai, Cheng-Fu Sun, Jia-Yuan He, Zhen-Yu Lin, Huan-Xin Liu, Fa-Rong Wang, Yan Onco Targets Ther Original Research BACKGROUND: The aim of this study was to investigate the clinicopathological characteristics, treatment, and survival of cystadenocarcinoma of the salivary gland. PATIENTS AND METHODS: Cases in the Surveillance, Epidemiology, and End Results database from 1991 to 2012 were identified. Factors significantly associated with survival were identified using Kaplan–Meier survival analysis and Cox proportional hazard regression. RESULTS: A total of 65 patients were identified; of these patients, 64 received surgical treatment, 25 underwent lymphadenectomy, and four (16.0%) patients had nodal metastasis and only one (2.1%) patient had poorly differentiated disease. The most common tumor location was the parotid gland (87.7%). The median follow-up was 55 months. None of the patients died of salivary gland malignant-tumor-related disease. The 5- and 10-year cause-specific survival rates were 97.0% and 81.4%, respectively. The 5- and 10-year overall survival rates were 84.6% and 60.7%, respectively. Surgical procedures, lymphadenectomy, and adjuvant radiotherapy did not affect survival. CONCLUSION: Salivary gland cystadenocarcinoma is extremely rare but has an excellent prognosis, and surgery is the mainstay of treatment. Dove Medical Press 2016-10-25 /pmc/articles/PMC5087798/ /pubmed/27822061 http://dx.doi.org/10.2147/OTT.S111247 Text en © 2016 Cai et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Cai, Cheng-Fu
Sun, Jia-Yuan
He, Zhen-Yu
Lin, Huan-Xin
Liu, Fa-Rong
Wang, Yan
Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
title Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
title_full Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
title_fullStr Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
title_full_unstemmed Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
title_short Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
title_sort clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087798/
https://www.ncbi.nlm.nih.gov/pubmed/27822061
http://dx.doi.org/10.2147/OTT.S111247
work_keys_str_mv AT caichengfu clinicopathologicalcharacteristicstreatmentandsurvivaloutcomesofcystadenocarcinomaofthesalivaryglandapopulationbasedstudy
AT sunjiayuan clinicopathologicalcharacteristicstreatmentandsurvivaloutcomesofcystadenocarcinomaofthesalivaryglandapopulationbasedstudy
AT hezhenyu clinicopathologicalcharacteristicstreatmentandsurvivaloutcomesofcystadenocarcinomaofthesalivaryglandapopulationbasedstudy
AT linhuanxin clinicopathologicalcharacteristicstreatmentandsurvivaloutcomesofcystadenocarcinomaofthesalivaryglandapopulationbasedstudy
AT liufarong clinicopathologicalcharacteristicstreatmentandsurvivaloutcomesofcystadenocarcinomaofthesalivaryglandapopulationbasedstudy
AT wangyan clinicopathologicalcharacteristicstreatmentandsurvivaloutcomesofcystadenocarcinomaofthesalivaryglandapopulationbasedstudy